Pages
- Helping patients by helping providers
- Interactive Map
- Equity Statement
- Privacy Policy
- Connect with Us
- Technical Assistance
- Surveillance & Evaluation Core
- Education & Outreach Core
- Clinical & Translational Core
- Best Practices Core
- Our Programs
- Accessibility Statement
- Sitemap
- Our Team
- Resources & Tools
- How We Help
Team Members
- Stacey C. Sigmon, PhD
- Sarah H. Heil, PhD
- Kelly Peck, PhD
- Nicole Greer, BS
- Sarah Jacobs, MD, MEd
- Ashley Mallett, PhD
- Laura Miller, BA
- Rene Cusick, MA
- Gail Rose, PhD
- Richard A. Rawson, PhD
- Stephen Crosswhite, BS
- Stephen T. Higgins, PhD
- Elias Klemperer, PhD
- Jennifer Noel, MSW
- Elinor Broy, MPH
- Valerie Harder, PhD, MHS
- Kate Peasley-Miklus, PhD
- Juan Napoles, MS
- Mark Bowman
- Robert Althoff, MD, PhD
- John Brooklyn, MD
- Megan Detweiler, RN, CARN
- Brady Heward, MD
- Peter Jackson, MD
- Sanchit Maruti, MD
- Marjorie C. Meyer, MD
- Felicia Brackett, MPH
- Marcy Doyle, DNP, MHS, MS, RN, CNL
- Katie Rosingana
- Jeanne Ryer, MSc, EdD
- Mary Lindsey Smith, PhD, MSW
- Janet Thomas BS, RN
Community Rounds
- Recovery Housing as a Bridge to Aligning Social and Medical Interventions
- Xylazine Trends and Public Health Implications for Rural Communities
- The Fourth Wave of the U.S. Overdose Crisis: Disseminating Incentive-Based Interventions for Stimulant Use Disorder into Rural Community Settings
- Assessment of Substance Use Disorder Stigma and Strategies for Addressing Stigma in Rural Areas
- Evidence-Based Treatment of PTSD in Individuals with OUD, and Innovative Approaches for Increasing Access to Care in Rural Communities
- Reaching People Where They're At: Smoking Cessation Treatment Delivery at Your Door
- A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior
- Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations
- Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers
- Three years of the COVID-19 Pandemic: What we've learned, and how it can make us better at treating rural patients with SUD
- Illicit Drug Supply: Fentanyl and Xylazine
- Recommendations for Culturally Recentering Reinforcement-Based Substance Use Disorder Interventions in Collaboration with Rural Tribal Communities
- Applying Motivation-Phase Interventions to Treat Tobacco Use Among People with Opioid Use Disorder
- Growing a Competent Workforce in a Rural State: The University of Kentucky Bell Addiction Medicine Scholar Program
- Practitioner and Stakeholder Perspectives on Opioid Use and Treatment Across Rural Northern New England
- Strategies for Distributing Intranasal Naloxone to Rural Communities
- Pregnancy, Parenting, And Substance Use: Stigma, Fear and a Call for Improved Messaging to our Families
- Alcohol Use Disorder in the Primary Care Setting: Best Practices for Rural Communities
- Tools to Increase COVID-19 Vaccine Uptake: Substance Use Disorder Populations in Rural Communities
- Social Determinants of Mental Health and Substance Use
- Cannabis Use and Cannabis Addiction in Rural Populations: Phenomenology, Intervention, Policy
- Peer Recovery as an Evidence-Based Practice: From Science to Impact
- Telehealth for Substance Use Disorders and Considerations for Rural Regions
- Motivational Interviewing: Evidence-Based Strategies and Principles for Guiding Conversations With Your Patients
- Understanding the Harm Reduction Approach: Principles and Practice
- Identifying SUD Bias and Addressing Stigma in the Clinical Setting
- Acute Pain Management Following Surgery
- Use of Sustained Release Buprenorphine (SRB) in the Out Patient Setting
- Treatment and Assessment of Co-occurring PTSD and SUDs
- Smartphone-based Financial Incentives to Promote Smoking Cessation Among Pregnant Women
- A Multigenerational Approach to Prevention & Treatment of SUDs
- Suicide and Substance Use Disorders
- Treatment of Stimulant Use Disorders
- SBIRT for Unhealthy Alcohol Use
- Prevention of Opioid Use Disorder in Women
Data Reports
- Perspectives on Opioid Use Disorder Treatment Access and Engagement from Rural Family Members and People in Treatment
- Baseline Needs Assessment Treatment Experiences in Rural Vermont
- Northern New York Needs Assessment: Rural Practitioners Report
- National Report: Rural Substance Use Disorder Stigma and Treatment Needs
- Stigma and Opioid Use Disorder in Northern New England
- Vermont Baseline Needs Assessment: Opioid Use Disorder Treatment Experiences in Rural Vermont
- Practitioner and Stakeholder Perspectives on Opioid Use and Treatment Across Rural Northern New England
- Concerns and Beliefs about Substance Use and Treatment among Northern New England Practitioners
- 2020 Rural Opioid Overdose Mortality Data Brief
- Maine Baseline Needs Assessment: Rural Practitioners and Stakeholders
- New Hampshire Baseline Needs Assessment: Practitioners and Community Stakeholders Report
- Maine Baseline Needs Assessment: Opioid Use Disorder Treatment Barriers and Beliefs
- Maine Baseline Needs Assessment: First Responders
- Maine Baseline Needs Assessment: Rural Practitioners and Stakeholders
- New Hampshire Baseline Needs Assessment: Barriers to Substance Use Disorder Treatment
- New Hampshire Baseline Needs Assessment: Practitioner Comfort Treating Substance Use Disorders
- New Hampshire Baseline Needs Assessment: COVID-19 Impact on Substance Use and Treatment
- Vermont Baseline Needs Assessment: Rural and Non-Rural Practitioners Report
- Vermont Baseline Needs Assessment: Rural Practitioners and Stakeholders Report
- Vermont Baseline Needs Assessment: Rural Report Summary
Resources
- Xylazine Test Strip User Guide, Wallet Sized
- Xylazine Resources
- Fentanyl Test Strip User Guide, Wallet Sized
- Fentanyl Detection in Drug Supply & Test Strip User Guide
- Narcan User Guide
- The Role of Stigma among Health Care Providers in the Treatment of Opioid Use Disorder
- Increased Fatal Overdoses Involving Stimulants and Fentanyl
- Rural-Urban Disparities in U.S. Cigarette Smoking Quit Ratios
- Increased Prevalence of Xylazine in Fatal Opioid Overdoses
- Medications for Opioid Use Disorder (MOUD)
- Expanded Naloxone Distribution to Reduce Rural Opioid Overdose Mortality
- COVID-19 Vaccine Uptake in Rural Populations with Substance Use Disorder
- Contingency Management for Stimulant Use Disorder Resources
- Motivational Interviewing Resources
- Substance Use Disorder Stigma Resources
- Buprenorphine Treatment for Opioid Use Disorder in Pregnant Women
- Financial Incentives for Smoking Cessation in Pregnancy
- Improved Adherence with Interim Buprenorphine Treatment (IBT)
- Peer-Based Recovery Support Services Delivered at Recovery Community Organizations
Posts by category
- Our Team
- Newsletters
- Naloxone vending machines; new wallet guide; and more
- Xylazine test strips; new data report; and more
- Xylazine resource guide; naloxone vending machine; and more
- Stigma & OUD; technical assistance feature; and more
- Clinician Office Hours; new reports; technical assistance feature
- Research on rural-urban smoking disparities; drug deactivation bags
- Research on xylazine and overdoses; MOUD resources; upcoming conferences and events
- Research on intranasal naloxone; behind the scenes of UVM CORA’s technical assistance
- Research on COVID-19 vaccine uptake and UVM CORA contingency management resources
- Peer recovery research and tools for providers
- Data Reports
- Resources